Nocturnal eating/drinking syndrome and neuroleptic-induced restless legs syndrome.

Abstract

Nocturnal eating/drinking syndrome secondary to neuroleptic-induced restless legs syndrome (RLS) occurred under treatment with low-dose haloperidol in a 51-year-old female schizophrenic patient. Polysomnographic investigation showed a low level of sleep efficacy, periodic leg movements, and a strict relationship between nocturnal eating episodes and non-rapid eye movement sleep. Her nocturnal eating and RLS were completely inhibited by clonazepam treatment. To our knowledge, this is the first published case of nocturnal eating/drinking syndrome secondary to neuroleptic-induced RLS.

• Authors: J Horiguchi, H Yamashita, S Mizuno, Y Kuramoto, A Kagaya, S Yamawaki, Y Inami
• Journal: International clinical psychopharmacology (Int Clin Psychopharmacol) Vol. 14 Issue 1 Pg. 33-6 (Jan 1999) ISSN: 0268-1315 [Print] England
• PMID: 10221640 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antipsychotic Agents

Topics

• Antipsychotic Agents (adverse effects)
• Circadian Rhythm (physiology)
• Drinking Behavior (physiology)
• Feeding Behavior (physiology)
• Female
• Humans
• Middle Aged
• Restless Legs Syndrome (chemically induced, physiopathology)
• Schizophrenia (drug therapy)
• Syndrome
• Time Factors